Multi-parameter diabetes risk evaluations
US9361429B2 · kind B2 · utility
11Cited by
18References
52Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2013 |
| Grant date | Jun 7, 2016 |
| Priority date | — |
| Expiry date | Mar 14, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H50/50
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods, systems and circuits evaluate a subject's risk of developing type 2 diabetes or developing or having prediabetes using at least one defined mathematical model of risk of progression that can stratify risk for patients having the same glucose measurement. The model may include NMR derived measurements of GlycA and a plurality of selected lipoprotein components of at least one biosample of the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.